-
Pioneering New Methods to Understand Protein Folding
Northwestern Medicine scientists have developed a new technique for measuring protein folding stability on an unprecedented scale, according to a new study published in Nature.
-
Scientists Uncover Why Some Cells Become Resistant to Cancer Therapies
Scientists have created a new synthetic biology approach to follow tumor cells over time, finding meaningful differences in why a cancer cell dies or survives in response to anti-cancer therapies.
-
Marijuana Use Linked to Epigenetic Changes
Recent and long-term marijuana use is linked to changes in the human genome, a new Northwestern Medicine study published in Molecular Psychiatry has found.
-
Student Investigates Link Between Neighborhood Safety and Pregnancy Outcomes
Pregnant people who report feeling unsafe in their neighborhoods are more likely to experience depression during pregnancy and have a baby with low birth weight, according to a study published in JAMA Network Open.
-
PA Program Celebrates White Coat Ceremony
On Friday, June 23, the Northwestern University Feinberg School of Medicine Physician Assistant Program’s class of 2025 celebrated the beginning of their medical journey with a white coat ceremony.
-
Understanding Metabolites Underlying Eye Development
Aerobic glycolysis, the process by which cells transform glucose into lactate, is essential for eye development in mammals, according to a new Northwestern Medicine study published in Nature Communications.
-
100-Year-Old Brain Mystery: What Does the Temporal Pole Do?
A recent Northwestern Medicine study has revealed that the brain’s temporal pole has critical functions in word comprehension, face recognition and the regulation of behavior.
-
Study Discovers Novel Region for BRD4 Transcription and Potential Therapeutic Target
Northwestern Medicine investigators have discovered a novel protein region that regulates DNA transcription elongation, suggesting a new therapeutic target for treating cancers and developmental disorders, according to findings published in Molecular Cell.
-
Metformin May Prevent Long COVID, Trial Finds
Metformin, a drug commonly used to treat diabetes, may prevent the development of “long COVID,” according to a clinical trial published in The Lancet Infectious Diseases.
-
Immunotherapy Improves Remission for Relapsed, Refractory Leukemia
A single infusion of CAR T-cell therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, according to a recent clinical trial published in The Lancet.
-
Broad-Spectrum Antibiotics Decrease Infection Rates in Pancreas Surgery
Administering broad-spectrum antibiotics before surgery to remove pancreas tumors may decrease the chances of surgical site infection, according to a recent study published in JAMA.
-
More Green Spaces Linked to Slower Biological Aging
Living near to green spaces were associated with slower biological aging, according to a Northwestern Medicine study published in Science Advances.
-
PA Student Competes in Olympic Trials for Race Walking
Anali Cisneros, a first-year student in Feinberg’s Physician Assistant (PA) Program, is an Olympic-level athlete in race walking and recently competed at the Olympic trials for the Tokyo Summer Olympic games.
-
Using Physiology to Predict Treatment Response in Eosinophilic Esophagitis
Northwestern Medicine scientists have identified and characterized common symptoms and patterns in Eosinophilic esophagitis, according to a study published in the journal Gastroenterology, findings that will help predict how patients will respond to treatment.
-
Designing Surfaces to Improve Bone Grafts
New research from Northwestern investigators has demonstrated a method for engineering bone surfaces to improve the quality of bone grafts.
-
Study Identifies Mechanisms Driving Immune Cell Recruitment During Inflammation
Northwestern Medicine investigators have discovered a novel mechanism that regulates neutrophil recruitment into tissue during inflammation, which could be targeted to treat different inflammatory diseases and conditions, according to a recent study published in the Journal of Clinical Investigation.
-
Checkpoint Inhibitor Plus Chemotherapy Improves Outcomes for Hodgkin Lymphoma
Adding a checkpoint inhibitor to conventional chemotherapy improved outcomes for patients with relapsed or refractory classic Hodgkin lymphoma, according to a Northwestern Medicine phase II clinical trial published in JAMA Oncology.
-
New Leadership in the Department of Medicine
Douglas E. Vaughan, MD, has announced his intention to step down as chair of The Department of Medicine, effective September 1; Susan Quaggin, MD, has been named as his successor.
-
CHET Juneteenth Celebration Addresses Health Disparities Experienced by the Black Community
The Center for Health Equity Transformation (CHET) held its annual Juneteenth Celebration of Black Culture, Art and Music webinar on June 15, and featured a discussion exploring persistent health disparities experienced by the Black community.
-
Northwestern Resident Wins Prestigious Burroughs Award for Medical Scientists
Sam Weinberg, ‘19 MD, PhD, has won the Burroughs Wellcome Fund Career Award for Medical Scientists, a prestigious award given to early-career physician-scientists.
